Cargando…
Population Pharmacokinetic Modeling and Simulations to Evaluate a Potential Dose Regimen of Testosterone Undecanoate in Hypogonadal Males
Intramuscular testosterone undecanoate is indicated as testosterone replacement in adult males with a deficiency in or absence of endogenous testosterone (hypogonadism). Intramuscular testosterone undecanoate 750 mg is approved to be administered at initiation and at 4 weeks, followed by a maintenan...
Autores principales: | Pastuszak, Alexander W., Bush, Mark, Curd, Laura, Vijayan, Saji, Priestley, Tony, Xiang, Qinfang, Hu, Yiqun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290951/ https://www.ncbi.nlm.nih.gov/pubmed/34269421 http://dx.doi.org/10.1002/jcph.1939 |
Ejemplares similares
-
Impact of Dose Delays and Alternative Dosing Regimens on Pertuzumab Pharmacokinetics
por: Liu, Stephanie N., et al.
Publicado: (2021) -
Pharmacokinetic and Pharmacodynamic Modeling of Serum Etrolizumab and Circulating β7 Receptor Occupancy in Patients With Ulcerative Colitis
por: Wei, Xiaohui, et al.
Publicado: (2017) -
Optimal injection interval for testosterone undecanoate treatment of hypogonadal and transgender men
por: Shankara Narayana, Nandini, et al.
Publicado: (2021) -
Model‐Based Approach to Predict Adherence to Protocol During Antiobesity Trials
por: Sharma, Vishnu D., et al.
Publicado: (2017) -
Interval type-2 Fuzzy control and stochastic modeling of COVID-19 spread based on vaccination and social distancing rates
por: Rafiei, H., et al.
Publicado: (2023)